Edition:
United States

Biostar Pharmaceuticals Inc (BSPM.OQ)

BSPM.OQ on NASDAQ Stock Exchange Capital Market

2.33USD
13 Jul 2018
Change (% chg)

-- (--)
Prev Close
$2.33
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
22,170
52-wk High
$5.96
52-wk Low
$1.18

Chart for

About

Biostar Pharmaceuticals, Inc. (Biostar) is a holding company. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops,... (more)
No analyst recommendations are available for .

Overall

Beta: 2.39
Market Cap(Mil.): $6.14
Shares Outstanding(Mil.): 2.64
Dividend: --
Yield (%): --

Financials

  BSPM.OQ Industry Sector
P/E (TTM): 5.90 214.97 33.20
EPS (TTM): 0.39 -- --
ROI: 2.66 -3.79 13.23
ROE: 2.66 -5.32 15.28

BRIEF-Biostar Pharmaceuticals Files For Non-Timely 10-Q

* BIOSTAR PHARMACEUTICALS FILES FOR NON-TIMELY 10-Q WITH U.S. SEC - SEC FILING Source http://bit.ly/2wLwd7M Further company coverage:

May 16 2018

BRIEF-Biostar Announces Receipt Of Nasdaq Continued Listing Deficiency Notice

* BIOSTAR ANNOUNCES RECEIPT OF NASDAQ CONTINUED LISTING DEFICIENCY NOTICE Source text for Eikon: Further company coverage:

Apr 23 2018

BRIEF-Biostar Pharmaceuticals Files For Non-Timely 10-K With U.S. SEC

* BIOSTAR PHARMACEUTICALS FILES FOR NON-TIMELY 10-K WITH U.S. SEC Source text: (https://bit.ly/2JfTgd0) Further company coverage:

Apr 02 2018

BRIEF-Biostar Pharmaceuticals Announces Plans To Launch A New Ecommerce Sales Platform

* BIOSTAR PHARMACEUTICALS, INC. ANNOUNCES PLANS TO LAUNCH A NEW ECOMMERCE SALES PLATFORM Source text for Eikon: Further company coverage:

Feb 21 2018

BRIEF-Biostar Says Shaanxi Aoxing Renewed GMP Certification

* SHAANXI AOXING PHARMACEUTICAL CO., LTD. RENEWED ITS GMP CERTIFICATION

Feb 07 2018

Earnings vs. Estimates